Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 3/2014

01-03-2014 | Letter to the Editor

Is there an association between Ro52/TRIM21 antibodies and rheumatoid factor in systemic sclerosis?

Authors: Sonal Mehra, Marie Hudson, Michael Mahler, Murray Baron, Marvin Fritzler, Canadian Scleroderma Research Group

Published in: Rheumatology International | Issue 3/2014

Login to get access

Excerpt

Dear Editor, …
Appendix
Available only for authorised users
Literature
1.
Peene I, Meheus L, De Keyser S, Humbel R, Veys EM, De Keyser F (2002) Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease. Ann Rheum Dis 61(10):929–933PubMedCrossRef
2.
Hudson M, Pope J, Mahler M, Tatibouet S, Steele R, Baron M, Canadian Scleroderma Research Group (CSRG), Fritzler M (2012) Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis. Arthritis Res Ther 14(2):R50PubMedCentralPubMedCrossRef
3.
Schulte-Pelkum J, Fritzler M, Mahler M (2009) Latest update on the Ro/SS-A autoantibody system. Autoimmun Rev 8(7):632–637PubMedCrossRef
4.
Takahata M, Bohgaki M, Tsukiyama T, Kondo T, Asaka M, Hatakeyama S (2008) Ro52 functionally interacts with IgG1 and regulates its quality control via the ERAD system. Mol Immunol 45(7):2045–2054PubMedCrossRef
5.
Retamozo S, Akasbi M, Brito-Zeron P, Bosch X, Bove A, Perez-de-Lis M, Jimenez I, Soto-Cardenas MJ, Gandia M, Diaz-Lagares C, Vinas O, Siso A, Perez-Alvarez R, Yague J, Ramos-Casals M (2012) Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjogren’s syndrome. Clin Exp Rheumatol 30(5):686–692PubMed
6.
Dugar M, Cox S, Limaye V, Gordon TP, Roberts-Thomson PJ (2010) Diagnostic utility of anti-Ro52 detection in systemic autoimmunity. Postgrad Med J 86(1012):79–82PubMedCrossRef
7.
Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Yazawa N, Tamaki K (2004) Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis. Br J Dermatol 151(4):803–808PubMedCrossRef
8.
Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K (2005) Clinical and laboratory features of scleroderma patients developing skeletal myopathy. Clin Rheumatol 24(2):99–102PubMedCrossRef
9.
Ueda-Hayakawa I, Hasegawa M, Kumada S, Tanaka C, Komura K, Hamaguchi Y, Takehara K, Fujimoto M (2010) Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis. Rheumatology (Oxford) 49(11):2135–2139CrossRef
10.
Pakozdi A, Nihtyanova S, Moinzadeh P, Ong VH, Black CM, Denton CP (2011) Clinical and serological hallmarks of systemic sclerosis overlap syndromes. J Rheumatol 38(11):2406–2409PubMedCrossRef
Metadata
Title
Is there an association between Ro52/TRIM21 antibodies and rheumatoid factor in systemic sclerosis?
Authors
Sonal Mehra
Marie Hudson
Michael Mahler
Murray Baron
Marvin Fritzler
Canadian Scleroderma Research Group
Publication date
01-03-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 3/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2728-x

Other articles of this Issue 3/2014

Rheumatology International 3/2014 Go to the issue

Short Communication

Smoking, disease activity, permanent damage and dsDNA autoantibody production in patients with systemic lupus erythematosus

Original Article

Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases

Short Communication

Effects of Pilates, McKenzie and Heckscher training on disease activity, spinal motility and pulmonary function in patients with ankylosing spondylitis: a randomized controlled trial

Original Article

Smoking and polymorphisms of genes encoding mannose-binding lectin and surfactant protein-D in patients with rheumatoid arthritis

Short Communication

Association study of CRP gene in systemic sclerosis in European Caucasian population

Letter to the Editors

Systemic lupus erythematosus activity and depression

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits